Advertisement

Related Videos

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Peter Clark, MA, MD, FRCP: A Payer Perspective

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Advertisement

Advertisement




Apr
30
Today In Oncology
AI-Powered, Next-Generation Sequencing Blood-Based Assay Evaluated for Detection of Post-HCT Relapse in AML and MDS
MIBC Pembrolizumab With Trimodal Therapy for Bladder Preservation
Long-Term Outcomes With Taletrectinib in ROS1-Positive NSCLC
Amivantamab in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer
Study Finds Prostate Cancer Overdiagnosis Rises ‘Substantially’ With Age
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo